Abstract Models of interest group politics can help public health professionals (PHPs) to
identify potential allies and establish mechanisms of sustainable political influence. This …

This paper presents the results from a qualitative study in which the Advocacy Coalition
Framework (ACF) was used to analyze deregulation of the distribution of medicine in …

In the past, drug policy in Switzerland was oriented mainly by the principle of prohibition, laid
down in the Federal Law on Narcotics. Primary prevention promoted a drug-free life, police …

Pharmaceutical policies form a substantial part of health care services, from the point of view
of both equity and efficiency goals. Expenditure on pharmaceuticals has been growing …

Although the power of the State to improve population health through public policies has
been acknowledged for hundreds of years—including, more recently, by proponents of the …

In this last article in the series the authors focus on the issue of researching and evaluating
pharmaceutical policy. The past five articles made an argument for why pharmaceutical …

Over the last two decades, Swiss drug policy has moved away from a prohibitionist to a'harm
reduction'model. This article uses the advocacy coalition framework (ACF) to understand this …

Almost every national and supranational health policy document accords high importance to
the need to listen to and 'empower'patients. The relationship between pharmaceutical policy …

Background In recent decades a range of advocacy organisations have emerged on the
drugs policy landscape seeking to shape the development of policy at national and …

Given the ever expanding role of civil society groups in advocating for changes in health
policy, the aim of this study was to explore whether there exists any association between …